drug
carglumic acid ODT
Marketedupdated 3mo agoby Recordati Rare Diseases Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying carglumic acid ODT
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 22, 2028
~1.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
FDA exclusivities (1)
- Jan 22, 2028ODE-345Orphan Drug (7y)1.5y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that